Novo Nordisk cuts Ozempic and Wegovy prices to $499/month for the uninsured, aiming to reduce reliance on unsafe compounded ...

Chances are when you've gone for a High Street eye test and the optician offers you an extra scan for an additional £10 to ...

This U.S. patent allowance secures long-term protection for our proprietary manufacturing process,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “With patent coverage in place and the ...

DelveInsight's Open-Angle Glaucoma Market Insights report includes a comprehensive understanding of current treatment ...

Dr. Lior Shaltiel, CEO, will speak at the Bioprocess International Conference in Boston, MA, one of the largest global gatherings for biomanufacturing innovation. His presentation is entitled “From ...

Tens of thousands of people in the UK are facing vision deterioration and even blindness without knowing it, experts have ...

Glaukos posts 30% revenue growth and pipeline expansion but faces regulatory and valuation risks. Read more on why I ...

In the fight against vision loss and blindness, eye banks play a crucial role.As intermediaries between donors and recipients ...

Tooth-in-eye surgery sounds like science fiction, but it can help people with severely damaged corneas see again. A patient ...

There is a surprising link between heart health and vision—and experts suggest that those who suffer a heart attack may also ...

A 68-year-old man presented to an outside emergency department with 2 days of progressive bilateral eyelid swelling.He had a ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a pioneering biopharmaceutical company developing ...